The import of vaccines for human use to the US is set to gradually increase from 2024 to 2028. The forecasted data shows a consistent annual growth, reflecting a stable demand for vaccines. The projected figures for 2024 indicate a starting value of 1.6066 million kilograms, reflecting a modest increase from the actual figures reported in 2023. The year-on-year percentage variation shows steady growth, indicative of a robust healthcare infrastructure that emphasizes preventative care through vaccines.

Future trends to watch for include:

Advancements in vaccine technology that could impact import needs and volumes.
Potential changes in global vaccine production localization strategies post-pandemic era.
Policy changes affecting healthcare funding and vaccine logistic complexities.